Lars Bärfacker
29Patents
7h-index
136Co-inventors
72Inventor score
Filing activity: Aug 18, 2003 → Aug 11, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9216978B2 | Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases | Chemistry; Metallurgy | 31 | Active |
| US9096592B2 | Bicyclic aza heterocycles, and use thereof | Chemistry; Metallurgy | 25 | Active |
| US8399471B2 | Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the same | Human Necessities | 17 | Active |
| US7687510B2 | Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes | Chemistry; Metallurgy | 12 | Active |
| US7566723B2 | 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use | Chemistry; Metallurgy | 10 | Expired |
| US8436180B2 | Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | Human Necessities | 7 | Active |
| US8252817B2 | Dipyridyl-dihydropyrazolones and their use | Chemistry; Metallurgy | 7 | Active |
| US7691854B2 | Dihydropyridine derivatives for use as human neutrophil elastase inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9745285B2 | Heteroaryl substituted pyrazoles | Chemistry; Metallurgy | 3 | Active |
| US10370339B2 | N-Methylbenzimidazoles as mIDH1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9370517B2 | Substituted pyrazolopyrimidines as Akt kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7230017B2 | Dihydropyridinone derivatives | Chemistry; Metallurgy | 2 | Expired |
| US9051316B2 | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use | Human Necessities | 1 | Active |
| US9085572B2 | 4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases | Chemistry; Metallurgy | 1 | Active |
| US10350206B2 | Benzyl substituted indazoles as BUB1 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9206185B2 | Imidazopyridazines as Akt kinase inhibitors | Human Necessities | 1 | Active |
| US8143411B2 | Substituted 6-phenylnicotinic acids and their use | Human Necessities | 1 | Active |
| US9604989B2 | Imidazopyridazines as Akt kinase inhibitors | Human Necessities | 0 | Active |
| US9260435B2 | Substituted imidazopyrazines as Akt kinase inhibitors | Human Necessities | 0 | Active |
| US8404709B2 | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof | Human Necessities | 0 | Active |
| US10428044B2 | 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones | Chemistry; Metallurgy | 0 | Active |
| US8324222B2 | Cyclically substituted furopyrimidine derivatives and use thereof | Human Necessities | 0 | Active |
| US8173665B2 | I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use | Chemistry; Metallurgy | 0 | Active |
| US8183246B2 | Acyclically substituted furopyrimidine derivatives and use thereof | Human Necessities | 0 | Active |
| US7498460B2 | Isophthalic acid derivatives | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.